C/EBPα is essential for the CMP to GMP transition and its expression is highest in the GMP (Supplementary Figure 1C), and as Trib2 degrades C/EBPα to drive AML disease [3, 4], this may account for the potent transformability of the GMP. The gene discussed is CEBPA; the disease is acute myeloid leukemia.